206 related articles for article (PubMed ID: 32107798)
1. Quality of Evidence Supporting Major Psychotropic Drug-Drug Interaction Warnings: A Systematic Literature Review.
Nguyen T; Liu X; Abuhashem W; Bussing R; Winterstein AG
Pharmacotherapy; 2020 May; 40(5):455-468. PubMed ID: 32107798
[TBL] [Abstract][Full Text] [Related]
2. Consistency of psychotropic drug-drug interactions listed in drug monographs.
Liu X; Hatton RC; Zhu Y; Hincapie-Castillo JM; Bussing R; Barnicoat M; Winterstein AG
J Am Pharm Assoc (2003); 2017; 57(6):698-703.e2. PubMed ID: 28844584
[TBL] [Abstract][Full Text] [Related]
3. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex
Abbas A; Al-Shaibi S; Sankaralingam S; Awaisu A; Kattezhathu VS; Wongwiwatthananukit S; Owusu YB
Int J Clin Pharm; 2022 Apr; 44(2):348-356. PubMed ID: 34811600
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
[TBL] [Abstract][Full Text] [Related]
5. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
[TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
7. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy.
Ismail M; Khan S; Khan F; Noor S; Sajid H; Yar S; Rasheed I
BMC Cancer; 2020 Apr; 20(1):335. PubMed ID: 32307008
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study.
Ismail M; Noor S; Harram U; Haq I; Haider I; Khadim F; Khan Q; Ali Z; Muhammad T; Asif M
BMC Health Serv Res; 2018 Oct; 18(1):762. PubMed ID: 30314487
[TBL] [Abstract][Full Text] [Related]
10. Potential drug-drug interactions in outpatients with depression of a psychiatry department.
Chen Y; Ding L
Saudi Pharm J; 2023 Feb; 31(2):207-213. PubMed ID: 36942274
[TBL] [Abstract][Full Text] [Related]
11. Drug safety in hospitalized patients with tuberculosis: Drug interactions and adverse drug effects.
Noor S; Ismail M; Khan F
Clin Respir J; 2021 Jan; 15(1):97-108. PubMed ID: 32949069
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients.
Tecen-Yucel K; Bayraktar-Ekincioglu A; Yildirim T; Yilmaz SR; Demirkan K; Erdem Y
J Manag Care Spec Pharm; 2020 Oct; 26(10):1291-1296. PubMed ID: 32996393
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different decision support software programs in perspective of potential drug-drug interactions in the oncology clinic.
Bektay MY; Seker Z; Eke HK; Turk HM; Izzettin FV
J Oncol Pharm Pract; 2023 Jul; 29(5):1178-1186. PubMed ID: 35642275
[TBL] [Abstract][Full Text] [Related]
14. Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit.
Lima EDC; Camarinha BD; Ferreira Bezerra NC; Panisset AG; Belmino de Souza R; Silva MT; Lopes LC
Front Pharmacol; 2020; 11():555407. PubMed ID: 33343344
[TBL] [Abstract][Full Text] [Related]
15. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
Pirnejad H; Amiri P; Niazkhani Z; Shiva A; Makhdoomi K; Abkhiz S; van der Sijs H; Bal R
Int J Med Inform; 2019 Jul; 127():18-26. PubMed ID: 31128828
[TBL] [Abstract][Full Text] [Related]
16. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
17. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
Ismail M; Khan F; Noor S; Haider I; Haq IU; Ali Z; Shah Z; Hassam M
Int J Clin Pharm; 2016 Oct; 38(5):1052-6. PubMed ID: 27365090
[TBL] [Abstract][Full Text] [Related]
18. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins.
Egger SS; Rätz Bravo AE; Hess L; Schlienger RG; Krähenbühl S
Drugs Aging; 2007; 24(5):429-40. PubMed ID: 17503898
[TBL] [Abstract][Full Text] [Related]
19. Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients.
Wagh BR; Godbole DD; Deshmukh SS; Iyer S; Deshpande PR
Indian J Crit Care Med; 2019 Apr; 23(4):170-174. PubMed ID: 31130787
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevancy and determinants of potential drug-drug interactions in chronic kidney disease patients: results from a retrospective analysis.
Saleem A; Masood I; Khan TM
Integr Pharm Res Pract; 2017; 6():71-77. PubMed ID: 29354553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
